Boehringer Ingelheim
Christina M. Shay is a seasoned professional in the field of epidemiology and real-world evidence (RWE), currently serving as Director of Global Epidemiology and RWE at Boehringer Ingelheim since November 2021. In this role, Christina manages complex RWE projects and oversees the development of global strategies for the company’s largest asset. Prior experience includes leadership positions at Genesis Research as Associate Director of Epidemiology and at the American Heart Association as Director of Impact and Health Metrics. Christina has also held academic roles as Research Assistant Professor at the University of North Carolina at Chapel Hill and Assistant Professor at the University of Oklahoma Health Sciences Center, among others. Educational credentials include a PhD in Epidemiology from the University of Pittsburgh and a Post Doctoral Fellowship in Cardiovascular Disease Epidemiology from Northwestern University.
This person is not in any teams
This person is not in any offices
Boehringer Ingelheim
116 followers
At Boehringer Ingelheim they create value through innovation with one clear goal: to improve the lives of patients. They develop breakthrough therapies and innovative healthcare solutions in areas of unmet medical need for both humans and animals. As a family owned company, they focus on long-term performance. They are powered by 50.000 employees globally who nurture a diverse, collaborative and inclusive culture. Learning and development for all employees is key, because your growth is their growth.